0000899243-20-012259.txt : 20200507 0000899243-20-012259.hdr.sgml : 20200507 20200507172344 ACCESSION NUMBER: 0000899243-20-012259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200505 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Gautam CENTRAL INDEX KEY: 0001738054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 20857725 MAIL ADDRESS: STREET 1: C/O AMNEAL PHARMACEUTICALS LLC STREET 2: 400 CROSSING BLVD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-05 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001738054 Patel Gautam C/O CEPHEID CAPITAL, LLC 277 W. 4TH STREET, UNIT 2 NEW YORK NY 10014 1 0 1 0 Class A Common Stock 2020-05-07 4 M 0 6459 A 162566 D Class A Common Stock 12887433 I See Footnote Restricted Stock Units 2020-05-05 4 A 0 46218 0.00 A Class A Common Stock 46218 46218 D Restricted Stock Units 2020-05-07 4 M 0 6459 0.00 D Class A Common Stock 6459 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020. /s/ Meredith Cook, Attorney-in-Fact 2020-05-07